Gene ontology annotations for UBC |
|
Experiment description of studies that identified UBC in exosomes |
1 |
Experiment ID |
46 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSC70|CD63|MHCII|CD81|CD86
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
17641064
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
Journal name |
JIMMU
|
Publication year |
2007 |
Sample |
Breast milk |
Sample name |
Breast milk - Colostrum |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.10-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QSTAR] Western blotting Immunoelectron Microscopy FACS |
|
|
2 |
Experiment ID |
494 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Osteoarthritic cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
496 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Healthy cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
20 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
✔
GOLGA2|cytochrome c
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
17956143
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
Journal name |
JPR
|
Publication year |
2007 |
Sample |
Colorectal cancer cells |
Sample name |
HT29 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Diafiltration |
Flotation density |
1.16 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
5 |
Experiment ID |
21 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
19837982
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
Journal name |
MCP
|
Publication year |
2009 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1215 |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.10-1.12 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [Orbitrap] Western blotting |
|
|
6 |
Experiment ID |
234 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-C3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
7 |
Experiment ID |
235 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
8 |
Experiment ID |
236 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
MHCC97L |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
9 |
Experiment ID |
237 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocytes |
Sample name |
MIHA |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RNA Sequencing |
|
|
10 |
Experiment ID |
200 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|TSG101|Alix|GAPDH
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22635005
|
Organism |
Homo sapiens |
Experiment description |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. |
Authors |
"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D." |
Journal name |
Nat Med
|
Publication year |
2012 |
Sample |
Melanoma cells |
Sample name |
B16-F10 SK-MEL-202 SK-MEL035 SK-MEL-265 |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
11 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
12 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
13 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
14 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
16 |
Experiment ID |
274 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
17 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
18 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
19 |
Experiment ID |
34 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
TSG101|CD63|MHCI|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19190083
|
Organism |
Homo sapiens |
Experiment description |
Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. |
Authors |
"Kesimer M, Scull M, Brighton B, Demaria G, Burns K, O'Neal W, Pickles RJ, Sheehan JK" |
Journal name |
FASEB
|
Publication year |
2009 |
Sample |
Tracheobronchial cells |
Sample name |
Tracheobronchial epithelial cells |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.16 -1.18 g/mL
|
Molecules identified in the study |
Protein mRNA |
Methods used in the study |
Mass spectrometry [QTOF] Western blotting Immunoelectron Microscopy FACS |
|
|
Protein-protein interactions for UBC |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
REV1 |
|
Reconstituted Complex |
 |
Homo sapiens |
|
2 |
EIF3A |
8661 |
Reconstituted Complex |
 |
Homo sapiens |
|
3 |
HIST2H2BE |
8349 |
Reconstituted Complex |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
4 |
H3F3C |
440093 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
5 |
SLC25A13 |
10165 |
Affinity Capture-MS |
 |
Homo sapiens |
|
6 |
C19orf44 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
7 |
HDAC4 |
|
Affinity Capture-Western |
 |
Homo sapiens |
|
8 |
TNIP1 |
10318 |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
9 |
PPP1CB |
5500 |
Affinity Capture-MS |
 |
Homo sapiens |
|
10 |
NPLOC4 |
55666 |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
11 |
UBE2A |
|
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
12 |
CCT5 |
22948 |
Affinity Capture-MS |
 |
Homo sapiens |
|
13 |
ZFAND2B |
|
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
14 |
HIST1H4A |
8359 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
15 |
SRPRB |
58477 |
Reconstituted Complex |
 |
Homo sapiens |
|
16 |
Itpr3 |
|
Affinity Capture-Western |
 |
Mus musculus |
|
17 |
TRIM26 |
7726 |
Affinity Capture-MS |
 |
Homo sapiens |
|
18 |
CRK |
1398 |
Affinity Capture-MS |
 |
Homo sapiens |
|
19 |
FKBP15 |
23307 |
Affinity Capture-MS |
 |
Homo sapiens |
|
20 |
TBX21 |
|
Affinity Capture-Western |
 |
Homo sapiens |
|
21 |
DNAJB2 |
3300 |
Affinity Capture-Western |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
22 |
ACTC1 |
70 |
Reconstituted Complex |
 |
Homo sapiens |
|
23 |
UBA1 |
7317 |
Protein-peptide |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Co-purification |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
24 |
BRCA1 |
672 |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
25 |
TAC3 |
|
Reconstituted Complex |
 |
Homo sapiens |
|
26 |
UBE3A |
7337 |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
27 |
ZC3H12A |
|
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
28 |
UBC |
7316 |
Protein-peptide |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Protein-peptide |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
29 |
CSNK2A1 |
1457 |
Affinity Capture-MS |
 |
Homo sapiens |
|
30 |
VHL |
|
Reconstituted Complex |
 |
Homo sapiens |
|
31 |
KEL |
|
Reconstituted Complex |
 |
Homo sapiens |
|
32 |
MID1 |
4281 |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
33 |
PSMD4 |
5710 |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Protein-peptide |
 |
Homo sapiens |
|
34 |
RIPK1 |
8737 |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
35 |
WDR26 |
80232 |
Affinity Capture-MS |
 |
Homo sapiens |
|
36 |
ASXL1 |
|
Reconstituted Complex |
 |
Homo sapiens |
|
37 |
MARC1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
38 |
MORC3 |
23515 |
Reconstituted Complex |
 |
Homo sapiens |
|
39 |
OTUD3 |
23252 |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
40 |
SLC5A6 |
8884 |
Reconstituted Complex |
 |
Homo sapiens |
|
41 |
POLH |
|
Two-hybrid |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
42 |
LAMC1 |
3915 |
Reconstituted Complex |
 |
Homo sapiens |
|
43 |
PPL |
5493 |
Reconstituted Complex |
 |
Homo sapiens |
|
44 |
IGF2BP3 |
10643 |
Affinity Capture-MS |
 |
Homo sapiens |
|
45 |
ANTXR1 |
84168 |
Reconstituted Complex |
 |
Homo sapiens |
|
46 |
DARS |
1615 |
Affinity Capture-MS |
 |
Homo sapiens |
|
47 |
PELI1 |
57162 |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
|
48 |
MAP3K7 |
|
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
49 |
NOD1 |
10392 |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
50 |
UBE2O |
63893 |
Biochemical Activity |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
51 |
UBE2K |
3093 |
Biochemical Activity |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
52 |
AP2A1 |
160 |
Reconstituted Complex |
 |
Homo sapiens |
|
53 |
RNF8 |
|
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
|
54 |
AMBRA1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
55 |
CDH2 |
1000 |
Reconstituted Complex |
 |
Homo sapiens |
|
56 |
STOM |
2040 |
Affinity Capture-MS |
 |
Homo sapiens |
|
57 |
BRCC3 |
79184 |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
58 |
TRABD |
80305 |
Affinity Capture-MS |
 |
Homo sapiens |
|
59 |
UBL4A |
8266 |
Affinity Capture-MS |
 |
Homo sapiens |
|
60 |
PSMD12 |
5718 |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
61 |
FBL |
2091 |
Affinity Capture-MS |
 |
Homo sapiens |
|
62 |
NBPF11 |
|
Reconstituted Complex |
 |
Homo sapiens |
|
63 |
TMEM201 |
199953 |
Reconstituted Complex |
 |
Homo sapiens |
|
64 |
RHOA |
387 |
Affinity Capture-Western |
 |
Homo sapiens |
|
65 |
DNAJB1 |
3337 |
Affinity Capture-MS |
 |
Homo sapiens |
|
66 |
OTUD7B |
56957 |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
67 |
EPS15L1 |
58513 |
Reconstituted Complex |
 |
Homo sapiens |
|
68 |
ACLY |
47 |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
69 |
HERC2 |
8924 |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
70 |
POLI |
|
Two-hybrid |
 |
Homo sapiens |
Far Western |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
Far Western |
 |
Homo sapiens |
Protein-peptide |
 |
Homo sapiens |
|
71 |
ASB11 |
|
Biochemical Activity |
 |
Homo sapiens |
|
72 |
Pam |
|
Biochemical Activity |
 |
Rattus norvegicus |
|
73 |
UCHL5 |
51377 |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
74 |
POLR2C |
5432 |
Affinity Capture-MS |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
75 |
RIPK2 |
|
Affinity Capture-Western |
 |
Homo sapiens |
|
76 |
PSMD5 |
5711 |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
77 |
METTL23 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
78 |
NSFL1C |
55968 |
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
79 |
RNF126 |
|
Biochemical Activity |
 |
Homo sapiens |
| | | |